Skip to Content
Investing Specialists

Top 10 Buys and Sells from Our Ultimate Stock-Pickers

Most managers are positioning themselves for the next stage of the market rally.

Mentioned: , , , , , , , , ,

By Greggory Warren, CFA | Senior Stock Analyst

Given the run-up in the markets during the second and third quarters, we weren't too surprised to see relatively few new investment ideas coming out of the top holdings, purchases, and sales of our Ultimate Stock-Pickers. Many of the stocks in these portfolios have converged on our analysts' fair value estimates. That said, our managers were still fairly active during the third quarter, either adding to or subtracting from their existing positions, building positions in new names, and selling some holdings outright. Based on some of the commentary we've seen so far from our Ultimate Stock-Pickers, it looks like many of them have adopted the habit of continually reevaluating their holdings as the equity markets (and prospects for the companies in their portfolios) move around during the early stages of the economic recovery. This has allowed them to more quickly make adjustments to their holdings whenever they see an opportunity to either lock in a gain, or put money to work in either a new name or an existing position.

Many of our Ultimate Stock-Pickers also noted that they continue to see opportunities in health care, something we not only highlighted during a review of second quarter holdings but saw further evidence of in some of the conviction purchases we noted in an early read of our manager's holdings for the third quarter. Health care stocks have been under pressure for much of this past year over concerns about the impact that a government-sponsored health-care plan would have on the industry's profitability. The question for investors, though, has been whether or not these near-term issues would derail the long-term positive impact that the aging of the baby boomers is expected to have on the industry overall. Judging from some of the more recent conviction purchases by our Ultimate Stock-Pickers, the answer still appears to be no. In fact, health care was one of the five areas where our managers were overweight the market, with slightly more than 14% of their aggregate holdings in the sector at the end of the third quarter, versus less than 13% for the S&P 500 Index (SPX). The other four areas were business services (at 7% versus 3% for the market), consumer goods (17% versus 11%), financial services (20% versus 14%), and media (5% versus 2%).

The Morningstar Ultimate Stock-Pickers Team does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.